About TRiCares
TRiCares is a Healthcare company based in Aschheim (Germany) founded in 2013. Minimally invasive tricuspid valve replacement system is developed. TRiCares has raised $102.84 million across 5 funding rounds from investors including GO CAPITAL, Andera Partners and European Union. Its chief executive, as recorded, is Ahmed Elmouelhi. TRiCares offers products and services including Topaz Heart Valve Prosthesis and Topaz Implantation System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is TRiCares GmbH.
Company details
The company was founded in 2013 in Aschheim, Germany, and operates within the medical device sector focused on cardiology. A catheter-based system for tricuspid valve replacement is being developed to treat tricuspid regurgitation without open-heart surgery. Clinical trials are conducted to evaluate efficacy and safety, while funding is secured to support ongoing research and development milestones. Leadership is provided by CEO Ahmed Elmouelhi.
- Headquarters Aschheim, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tricares.com
- Social LinkedIn
- Legal Name Tricares Gmbh
- Total Equity Funding$102.84M (USD)
in 5 rounds
- Latest Funding Round$23.26M (USD), Debt – Conventional
Jan 2026
- InvestorsGO CAPITAL
& 10 more
Products & Services of TRiCares
TRiCares offers a comprehensive portfolio of products and services, including Topaz Heart Valve Prosthesis and Topaz Implantation System.
Minimally invasive system for replacing tricuspid valves in heart patients.
Tool for catheter-based heart valve implantation procedures.
Funding Insights of TRiCares
TRiCares has successfully raised a total of $102.84M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $23.26 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $102.84M
- Total Rounds 5
- Last Round Debt – Conventional — $23.26M
- First Round $2.56M
(Dec 2018)
- Investors Count 11
All 5 funding rounds of TRiCares with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $23.26M | Debt – Conventional | – | – | |
| Jul 2024 | $50M | Series D | – | – | – |
| Sep 2022 | $52.84M | Series C | – | 415 CAPITAL | |
| Nov 2021 | $56,392 | Grant | – | – | |
| Dec 2018 | $2.56M | Grant | – | – |
11 investors in total: 11 institutional.
Investors in TRiCares
TRiCares has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include GO CAPITAL, Andera Partners and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in medical technology innovations. | 415capital.com | Munich, Germany | ||
Capital is provided to firms for growth, buyouts, and acquisitions. | 2001 | anderapartners.com | Paris, France | |
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe | biomedvc.com | Basel, Switzerland | ||
Growth and acquisition investments are managed by Credit Mutuel Equity. | creditmutuel-equity.eu | Paris, France | ||
Private equity investments are directed toward multiple sectors. | 2003 | gocapital.fr | Rennes, France | |
Karista is recognized as an early-stage venture capital firm. | 2001 | karista.vc | Paris, France | |
Investments are made in early-stage healthcare startups. | wellington-partners.com | Munich, Germany | ||
High-tech industries are targeted for investments by Bayern Kapital. | bayernkapital.de | Landshut, Germany | ||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
| eib.org |
Investor details for TRiCares
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TRiCares
1 people are tracked at TRiCares (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ahmed Elmouelhi | CEO | Leadership |
Complete people profiles for TRiCares
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TRiCares
3 dated milestones of TRiCares across 13 years, from founding to its latest funding, stage changes and deals.
- Founded TRiCares is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Debt – Conventional, of $23.3M.
Web traffic of TRiCares
The website of TRiCares (tricares.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 187.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tricares
Complete news archive for TRiCares
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TRiCares
TRiCares was founded in 2013 and raised its 1st funding round 5 years after it was founded.
TRiCares is headquartered in Aschheim, Germany. It is registered at Aschheim, Bavaria, Germany.
Ahmed Elmouelhi is the CEO of TRiCares, as recorded in our data.
TRiCares is a funded company, having raised a total of $102.84M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.56M, raised on Dec 2018.
The company was founded in 2013 in Aschheim, Germany, and operates within the medical device sector focused on cardiology. A catheter-based system for tricuspid valve replacement is being developed to treat tricuspid regurgitation without open-heart surgery. Clinical trials are conducted to evaluate efficacy and safety, while funding is secured to support ongoing research and development milestones. Leadership is provided by CEO Ahmed Elmouelhi.
TRiCares offers Topaz Heart Valve Prosthesis and Topaz Implantation System.
TRiCares has 11 investors. Key investors include GO CAPITAL, Andera Partners, European Union, 415 Capital, and BioMedPartners.
TRiCares operates through Tricares Gmbh.